Pliant Therapeutics Inc
F:9PT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pliant Therapeutics Inc
F:9PT
|
US |
|
R
|
Roots Corp
F:4RO
|
CA |
|
N
|
Nordson Corp
F:ND1
|
US |
|
N
|
Netflix Inc
F:NFC
|
US |
|
Daiichi Sankyo Co Ltd
F:D4S
|
JP |
|
G
|
Gen Digital Inc
DUS:SYM
|
US |
|
C
|
CVS Health Corp
BMV:CVS
|
US |
|
S
|
Stericycle Inc
XMUN:SY9
|
US |
|
P
|
Potbelly Corp
F:PTB
|
US |
|
Enterprise Financial Services Corp
NASDAQ:EFSC
|
US |
|
Strongpoint ASA
F:PGT
|
NO |
|
D
|
Daiichi Sankyo Co Ltd
DUS:D4S
|
JP |
|
V
|
VGP NV
F:4V1
|
BE |
|
Chrysalis Investments Ltd
F:285
|
GG |
Wall St Price Targets
9PT Price Targets Summary
Pliant Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
9PT is 3.186 EUR with a low forecast of 2.366 EUR and a high forecast of 3.69 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9PT's stock price target?
Price Target
3.186
EUR
According to Wall Street analysts, the average 1-year price target for
9PT is 3.186 EUR with a low forecast of 2.366 EUR and a high forecast of 3.69 EUR.